Feedback Share Discussion Threads

[ducatiman] 25/11/2018 11:42

No less Gym! Good to see LR2 getting to the bottom of things!

[gymratt] 25/11/2018 10:37

That in itself should boost the SP, Duc. I'm expecting a 'heavy hitter'.

[ducatiman] 25/11/2018 07:57

Good find LR2. tim, we are doing very well without a CEO so yes, when an appointment is made it could be very interesting to see who gets the post!

[tim000] 24/11/2018 19:07

As a newcomer to this board, I'm probably not up to speed with everyone else. Still, I found this interesting:

hxxps://cristaltherapeutics.com/about-us/supervisory-board/

Clearly Dr Riddell and Simon Sturge know each other quite well, probably going back to their Celltech days. Dr Riddell has past associations with GE Healthcare too. It seems to me that Drs Riddell and Sturge (and their respective connections with GE Healthcare and Merck) are going to be central to FDBK's future prospects. So any incoming CEO is going to have to be very special (in terms of their own connections in the industry) to justify their appointment. It will be very interesting to see if the post is filled, or just left vacant for a while.

[lr2] 24/11/2018 19:00

Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Aker, Medhat, M.B.B.S., M.Ch., M.D.(Res.)1; Ganeshan, Balaji, Ph.D.2; Afaq, Asim, M.B.B.S., F.R.C.R.2; Wan, Simon, M.B.B.S., M.Sc., F.R.C.R.2; Groves, Ashley, M.B.B.S., M.D.2; Arulampalam, Tan, M.B.B.S., M.D., F.R.C.S.1

Diseases of the Colon & Rectum: November 15, 2018 - Volume Publish Ahead of Print - Issue - p



The Video Abstract was a nice touch.

[petekand] 23/11/2018 22:32

Thanks for all your help LR2 but this sounds a job for my son over the weekend.
I may have clicked on something whilst browing their site on my mobile device but doesn't explain for me why it happens on my work laptop. Thanks again.

[lr2] 23/11/2018 21:31

OK, it looks as though you are assumed to be a person authorised to modify the web site. Somewhere along the way you have found a link to the login for authorised personnel on the web site and it is now sitting on your PC / mobile and popping up every time you go to the site. You probably need to find and run the 'cleaning and optimizing' routine used by your internet security protocol software. As I don't know what security system you use then you are pretty much on your own from this point onward.

[petekand] 23/11/2018 21:14

Now your scaring me ha!
That is strange as I have been getting it on my mobile device and my work laptop. This is exactly what it says before asking me for a username/password and it keeps popping up on every link I click;

"Log in to feedback-medical.mobius.mobiusclients.co.uk"

[lr2] 23/11/2018 21:02

Not me Pete. I don't get a login pop-up or any glitches. Are you accessing from a PC or a mobile? I'd be more concerned about someone attempting to grab your details from a possible false login page than the glitches you've mentioned.

[petekand] 23/11/2018 20:59

I do also appreciate when a public listed company promptly updates shareholder information in accordance to listing rules.

[petekand] 23/11/2018 20:47

Does anybody else get an annoying pop up message when visiting the FDBK website asking for a login which keeps appearing as you navigate the different pages. The homepage also glitches as I scroll down and it has been going on for weeks.

[ducatiman] 23/11/2018 18:26

The only thing unexciting with this company is the share price That will change.

[tim000] 23/11/2018 17:58

Ah, you knew that already! I don't think they've announced the size of the royalties, but in any case they won't be material for a while - at which point I guess the company will inform the market.

[ged5] 23/11/2018 17:52

Thanks tim!

See post 102.

[tim000] 23/11/2018 17:17

You may already know that Stonechecker was sold to IQAI, for about £40k plus royalties on future sales. At the moment, royalty payments to FDBK will be de minimis, I think IQAI has only recently announced its first sale.

[ged5] 23/11/2018 16:06

I see FDBK tweeted about RSNA earlier this afternoon.

Referring back to the latest news item on the website, there are no less than 7 presentations featuring TexRAD.

Google some of the presenters and you'll find some leaders in their field of research.

Some very clever people in Textural Analysis and Radiomics.

I also note StoneChecker is the title of one of the presentations. Another source of income. Anyone know how much?

[tim000] 22/11/2018 15:27

To be fair this news is pretty marginal. To get the share price moving up to what we believe would be a more appropriate level, we need a succession of positive trading updates, ideally based on new sales but also any news on product developments, marketing collaborations and progress on getting FDA approval. Versarian's Neill Ricketts is a role model in that respect, and VRS's share price has risen correspondingly. (Of course VRS's graphene has a much larger prospective market than that of FDBK, although both have achieved worldwide interest.)

[ged5] 22/11/2018 15:15

Aren't results due in the next six trading days?

An outstanding outlook statement is needed to get this moving.

[ducatiman] 22/11/2018 15:05

And the market's usual greeting to good news from fdbk, lol.

[ged5] 22/11/2018 13:13

"This successful audit demonstrates our dedication to ensuring that our products are safe, effective and reliable. We strive to meet and exceed our customer's expectations and international quality standards, in the face of ongoing change within the regulatory landscape of our target markets."

Today's RNS

[ducatiman] 22/11/2018 13:11

Well done fdbk

[ged5] 22/11/2018 12:07

Thanks to LR2 I've incorporated some of the quotes from the medical experts into the header.

Maybe an old piece but for someone new like myself I found the article enlightening.
Link also in the header for easy reference.

Also I hadn't realised that Seimans used TEXRAD.

[gymratt] 20/11/2018 15:27

Thanks for your thoughts, I concur .
I guess Riddell is not at liberty to disclose @ < 3% as you say . A matter of confidentiality and professionalism on his part not to let it slip in the interview.

[siddle] 20/11/2018 14:57

Gym, it's not for Riddle to disclose their identity. If they wanted the market to know then they would have acquired over 3% and issued a TR1 notification. If we don't see this over the week, then we must assume they are at less than the reporting threshold but I'm happy with that...